Please assess the completion status of the following clinical trial:

Trial Title: Non-Invasive Shunt Quantification in Interatrial Communication

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* cooperate patients over 18 years, having a OS ASD with an indication of interventional closure according to the European Cardiology society guidelines of 2010.~* Patients with significant shunt (signs of right ventricular volume overload) and Pulmonary Vascular Resistance (PVR) \<5WU~* ASD, regardless the size, with suspicion of paradoxal embolism~* Patients with PVR \> or egal 5 WU but \<2/3 Systemic Vascular Resistance or Pulmonary Arterial Pressure \< 2/3 systemic pressure and evidence of net Left-to Right shunt (Qp/Qs \> 1,5)~* with the French Social Security System~Exclusion Criteria:~* Pregnant women and breastfeeding women~* Difficulties of cooperation (patient under assisted ventilation)~* Chronic Obstructive Pulmonary disease or respiratory failure~* Complex congenital heart disease~* Antiplatelet contraindication~* Patients under protection, vulnerable patients~* No consent~* Contraindication of the non-invasive devices~* Physioflow (Manatec, France): patients with pacemaker, with a cardiorespiratory support and assistance, severe aortic insufficiency~* Innocor (Innovision, Odense, Denmark): to our knowledge, and according to the user instructions, there is no contraindication

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- patients with Atrial septal defect type Ostium Secundum (Type: EXPERIMENTAL): patients with Atrial septal defect type Ostium Secundum, eligible for an interventional closure

Based on this trial design, predict the completion outcome and termination type (if applicable).